San Francisco Bay Area biotech stories.
Wednesday, December 8, 2010
StemCells wins OK for spinal cord trial
A Swiss researcher will lead a Phase I/II trial using neural stem cells from Palo Alto's StemCells Inc. to repair spinal cord injuries that are less than a year old.
Share to Twitter
Share to Facebook
Share to Pinterest
Post a Comment
Post Comments (Atom)